(Q46332785)

21 December 2017

title

Analysis of the delay components in the treatment of status epilepticus (English)

1 reference

21 December 2017

1 reference

Leena Kämppi

1

1 reference

21 December 2017

Harri Mustonen

series ordinal

2

1 reference

21 December 2017

Seppo Soinila

series ordinal

3

1 reference

21 December 2017

publication date

1 August 2013

1 reference

21 December 2017

published in

Neurocritical Care

1 reference

21 December 2017

volume

19

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

10-18

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s12028-013-9862-x

exact match

0 references

cites work

Determinants of mortality in status epilepticus

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Refractory status epilepticus: effect of treatment aggressiveness on prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Hippocampal Pyramidal Cell Loss in Human Status Epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Molecular pathways controlling inhibitory receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Refractory status epilepticus: frequency, risk factors, and impact on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

A clinical, radiological and outcome study of status epilepticus from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Time to treatment in prolonged seizure episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Incidence of status epilepticus in Rochester, Minnesota, 1965-1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Propofol in the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Status epilepticus at an urban public hospital in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

What is the evidence to use new intravenous AEDs in status epilepticus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

A randomized trial for the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

EFNS guideline on the management of status epilepticus in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

A "malignant" variant of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

Outcomes in 140 critically ill patients with status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-013-9862-X

A prehospital randomized trial in convulsive status epilepticus

21 January 2018

1 reference

12 December 2020

The biochemical basis and pathophysiology of status epilepticus

1 reference

12 December 2020

Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study

1 reference

12 December 2020

Status epilepticus. Causes, clinical features and consequences in 98 patients

1 reference

12 December 2020

Predictors of functional disability and mortality after status epilepticus

1 reference

12 December 2020

10.1007/S12028-013-9862-X

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017